Zimmer Biomet Holdings Inc. (ZBH)
$85.50
$0.19
(0.22%)
As on 22-May-2026 18:15EDT
Market cap
$16,740 Mln
Revenue (TTM)
$8,409 Mln
P/E Ratio
22.4
P/B Ratio
1.3
Div. Yield
1.1 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$523 Mln
-
ROE
0.1 %
-
ROCE
3.6 %
-
Industry P/E
45.4
-
EV/EBITDA
10.2
-
Debt to Equity
0.4
-
Book Value
$--
-
EPS
$3.9
-
Face value
--
-
Shares outstanding
193,462,482
10 Years Aggregate
CFO
$14,033.30 Mln
EBITDA
$21,015.70 Mln
Net Profit
$5,184.30 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zimmer Biomet Holdings (ZBH)
| -4.9 | -7.8 | -13.4 | -7.8 | -14.1 | -12.0 | -3.0 |
|
BSE Sensex*
| -9.7 | -0.2 | -7.0 | -6.4 | 7.4 | 8.6 | 11.7 |
|
S&P 100
| 7.4 | 6.7 | 10.0 | 30.6 | 24.2 | 14.5 | 15.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zimmer Biomet Holdings (ZBH)
| -14.9 | -13.1 | -4.5 | 3.5 | -17.0 | 3.8 | 45.4 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zimmer Biomet Holdings (ZBH)
|
85.5 | 16,740.3 | 8,409.2 | 761.3 | 14.3 | 5.5 | 22.4 | 1.3 |
| 87.4 | 152,878.9 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 24.6 | 2.9 | |
| 147.6 | 40,490.7 | 21,365.0 | 1,138.0 | 9.9 | 4.6 | 25.6 | 1.7 | |
| 57.8 | 84,945.2 | 20,615.0 | 3,553.0 | 10.0 | 14.5 | 23.9 | 3.3 | |
| 172.0 | 121,113.7 | 24,778.0 | 3,689.0 | 18.7 | 7.1 | 33.1 | 2.3 | |
| 85.8 | 49,392.1 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 46.4 | 4.6 | |
| 559.4 | 44,124.8 | 4,446.1 | 1,095.2 | 23.5 | 70.3 | 41.2 | 28.4 | |
| 438.1 | 155,158.7 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 53.2 | 8.9 | |
| 316.5 | 120,183.6 | 25,270.0 | 3,337.0 | 18.5 | 15.1 | 36.2 | 5.2 | |
| 448.3 | 166,995.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 24.7 | 3.2 |
Shareholding Pattern
View DetailsAbout Zimmer Biomet Holdings (ZBH)
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products,... including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Read more
-
COO, President, CEO & Director
Mr. Ivan Tornos
-
COO, President, CEO & Director
Mr. Ivan Tornos
-
Headquarters
Warsaw, IN
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Zimmer Biomet Holdings (ZBH)
What is the current share price of Zimmer Biomet Holdings Inc (ZBH) Today?
The share price of Zimmer Biomet Holdings Inc (ZBH) is $85.50 (NYSE) as of 22-May-2026 18:15 EDT. Zimmer Biomet Holdings Inc (ZBH) has given a return of -14.12% in the last 3 years.
What is the current PB & PE ratio of Zimmer Biomet Holdings Inc (ZBH)?
The P/E ratio of Zimmer Biomet Holdings Inc (ZBH) is 22.42 times as on 22-May-2026, a 51 discount to its peers’ median range of 45.40 times.
The P/B ratio of Zimmer Biomet Holdings Inc (ZBH) is 1.30 times as on 22-May-2026, a 58 discount to its peers’ median range of 3.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.26
|
1.40
|
|
2024
|
23.36
|
1.69
|
|
2023
|
24.79
|
2.03
|
|
2022
|
115.60
|
2.23
|
|
2021
|
66.03
|
2.09
|
What is the 52 Week High and Low of Zimmer Biomet Holdings Inc (ZBH)?
The 52-week high and low of Zimmer Biomet Holdings Inc (ZBH) are Rs 108.29 and Rs 79.12 as of 25-May-2026.
What is the market cap of Zimmer Biomet Holdings Inc (ZBH)?
Zimmer Biomet Holdings Inc (ZBH) has a market capitalisation of $ 16,740 Mln as on 22-May-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Zimmer Biomet Holdings Inc (ZBH)?
Before investing in Zimmer Biomet Holdings Inc (ZBH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.